Accrued Liabilities and Other Liabilities

6 Months Ended

Jun. 30, 2023

Payables and Accruals [Abstract]

Accrued Liabilities and Other Liabilities

Accrued liabilities and other liabilities consisted of the following (in thousands):

	June 30,		December 31,
	2023		2022
Accrued liabilities:
Accrued clinical expense	$	41,584	$	37,604
Accrued manufacturing expense	6,114		6,605
Accrued development expense	4,629		20,107
Accrued compensation and benefits	34,932		40,208
Accrued commercial expense	4,547		3,941
Accrued royalty expense	869		—
Accrued adjustments to product revenue	1,922		152
Lease liability (current)	7,961		7,844
Other accrued expenses	4,925		4,126
Total accrued liabilities	$	107,483	$	120,587
Other liabilities	$	3,380	$	3,022

Other liabilities as of June 30, 2023 and December 31, 2022 consisted primarily of clinical trial-related liabilities.